Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Califf

Showing results (221-230 of 770) with videos related to

Pageof 77
Sort By:
Kidney International|June 20, 2008
Negative trials in nephrology: what can we learn?James E Novak, Jula K Inrig, Uptal D Patel, et al.
Journal of the American College of Cardiology|March 19, 2004
Meta-analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplastyJohn A Bittl, Derek P Chew, Eric J Topol, et al.
Clinical Pharmacology and Therapeutics|April 8, 2021
When Are Treatment Blinding and Treatment Standardization Necessary in Real-World Clinical Trials?Jonathan H Watanabe, Gregory E Simon, Michael Horberg, et al.
Lancet (London, England)|July 20, 2002
Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newbornMartin P Moya, Andrew J Gow, Robert M Califf, et al.
Annals of Internal Medicine|June 17, 2020
COVID-19 Clinical Trials: A Teachable Moment for Improving Our Research Infrastructure and RelevanceStephen E Kimmel, Robert M Califf, Natalie E Dean, et al.
The American Journal of Cardiology|September 18, 2004
Is rhythm control superior to rate control in patients with atrial fibrillation and congestive heart failure?Sana M Al-Khatib, Linda K Shaw, Kerry L Lee, et al.
Health Affairs (Project Hope)|August 7, 2008
Use of larger versus smaller drug-safety databases before regulatory approval: the trade-offsShelby D Reed, Kevin J Anstrom, Damon M Seils, et al.
American Heart Journal|August 10, 2010
A review of dyspnea in acute heart failure syndromesRyenn L West, Adrian F Hernandez, Christopher M O'Connor, et al.
Nature Reviews. Drug Discovery|February 25, 2017
Accelerating development of scientific evidence for medical products within the existing US regulatory frameworkRachel E Sherman, Kathleen M Davies, Melissa A Robb, et al.
The New England Journal of Medicine|March 12, 2015
Compliance with results reporting at ClinicalTrials.govMonique L Anderson, Karen Chiswell, Eric D Peterson, et al.
Pageof 77

Showing results (221-230 of 770) with videos related to

Sort By:
Pageof 77
Kidney International|June 20, 2008
Negative trials in nephrology: what can we learn?James E Novak, Jula K Inrig, Uptal D Patel, et al.
Journal of the American College of Cardiology|March 19, 2004
Meta-analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplastyJohn A Bittl, Derek P Chew, Eric J Topol, et al.
Clinical Pharmacology and Therapeutics|April 8, 2021
When Are Treatment Blinding and Treatment Standardization Necessary in Real-World Clinical Trials?Jonathan H Watanabe, Gregory E Simon, Michael Horberg, et al.
Lancet (London, England)|July 20, 2002
Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newbornMartin P Moya, Andrew J Gow, Robert M Califf, et al.
Annals of Internal Medicine|June 17, 2020
COVID-19 Clinical Trials: A Teachable Moment for Improving Our Research Infrastructure and RelevanceStephen E Kimmel, Robert M Califf, Natalie E Dean, et al.
The American Journal of Cardiology|September 18, 2004
Is rhythm control superior to rate control in patients with atrial fibrillation and congestive heart failure?Sana M Al-Khatib, Linda K Shaw, Kerry L Lee, et al.
Health Affairs (Project Hope)|August 7, 2008
Use of larger versus smaller drug-safety databases before regulatory approval: the trade-offsShelby D Reed, Kevin J Anstrom, Damon M Seils, et al.
American Heart Journal|August 10, 2010
A review of dyspnea in acute heart failure syndromesRyenn L West, Adrian F Hernandez, Christopher M O'Connor, et al.
Nature Reviews. Drug Discovery|February 25, 2017
Accelerating development of scientific evidence for medical products within the existing US regulatory frameworkRachel E Sherman, Kathleen M Davies, Melissa A Robb, et al.
The New England Journal of Medicine|March 12, 2015
Compliance with results reporting at ClinicalTrials.govMonique L Anderson, Karen Chiswell, Eric D Peterson, et al.
Pageof 77